Search results for: 'modal 08 00 00 00'

15 Dec 2015  |  Asia Pacific  |  Market Research

Analysis of the Medical Imaging Market in Selected ASEAN Countries

Growth and Trends in CT, MR, PET, and SPECT Modalities

Infographics

×

This research service provides an analysis of the medical imaging market in Indonesia, Malaysia, Singapore, and Thailand. It provides a detailed analysis of current trends, market size, revenue forecasts, and drivers and restraints for the computed tomography (CT), medical resonance (MR), Positron emission tomography (PET), and single-photon emissi...

05 Nov 2015  |  North America  |  Market Research

Analysis of the US Breast Imaging Systems Market

A Guide to One of Medical Imaging’s Key Multi-modality Hubs

Infographics

×

This research service presents an analysis of the breast imaging systems market in the United States. It provides an in-depth analysis of the current trends, market size, revenue forecast, drivers and restraints, market penetration, and market attractiveness. Segments that are covered include X-ray mammography (with analog, digital radiography, co...

17 Aug 2022  |  Global  |  Technology Research

Therapeutic Advances in Amyloidosis

Research Efforts and Technology Developments through Partnerships and Collaborations will Push New Therapeutic Modalities into Treatment Regimens.

Infographics

×

Amyloidosis is a rare disease caused by the accumulation and the deposition of proteins such as immunoglobulin light-chain protein in AL amyloidosis and misfolded transthyretin (TTR) protein in ATTR amyloidosis. There are a few other types of amyloidosis as well, which are either a result of a preexisting condition or are not highly prevalent. Vari...

Frost & Sullivan provides comprehensive insights into the global biologics contract development and manufacturing organization (bio-CDMO) market, including emerging trends, growth opportunities, and profiles of leading bio-CDMOs and their business model evolution. The growth of next-generation biologics and personalized therapies and the emergence ...

05 Sep 2022  |  Global  |  Technology Research

Technology Growth Opportunities for Exosome-Mediated Drug Delivery

Exosomes Are Promising Delivery Carriers for Advanced Therapeutics

Infographics

×

Exosome-mediated drug delivery is a promising alternative to conventional drug delivery methods, making rapid strides in the biopharmaceutical industry because of the safety and efficacy advantages exosomes offer as nanocarriers over synthetic nanoparticles. The widely explored concepts of nanomedicine, nucleic acid therapeutics, and cell-free vacc...

10 May 2023  |  Global  |  Market Research

Growth Opportunities in the Biologics Contract Development and Manufacturing Organization Sector

Value Chain Expansion to Support Next generation Biologics Drives Future Growth Potential

Infographics

×

This research service provides an overview of the global biologics contract development and manufacturing organization (bio-CDMO) market and a 6-year market revenue forecast (2023 to 2028). The geographic scope covers three key regions, namely North America (NA); Europe; and Asia-Pacific (APAC). The report offers a detailed segment analysis of...

This research service provides the market revenues and trends of various breast imaging modalities in the Chinese market. Increasing incidence of breast cancer, awareness among the population, healthcare reforms, and expansion of breast screening to rural areas accelerate the growth of breast imaging market in China. Increasing disposable income, ...

This study analyzes the Brazilian medical imaging market from 2011 to 2017, focusing exclusively on computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound. The analyzed total market is expected to growth with a single-digit CAGR for 2012 to 2017. This growth rate is mainly driven by the C-class economic growth that allows increa...

By 2023, biologics constituted 44% of the therapeutic pipeline, with antibodies and recombinant proteins as leading categories. Nevertheless, advancements in these fields decelerated, with most of the expansion happening in heterologous cell treatments, synthetic nucleic acids, and viruses. The global biologics pipeline will shift toward more compl...